MRNA has almost SEVEN TIMES the market cap of Novavax.
Novavax is well on their way to approvals of their safe, effective, protein-based vaccine ALL AROUND THE WORLD. Including the EU very soon (where Moderna is slowly being disengaged).
NVAX has manufacturing capacity of more than 2Billion doses/year.
Now - which has more upside potential?
So you like Moderna - but why wouldn't you own both?
精彩评论